
Sign up to save your podcasts
Or


Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".
By American College of Rheumatology4.9
6464 ratings
Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".

504 Listeners

298 Listeners

128 Listeners

3,374 Listeners

1,150 Listeners

122 Listeners

120 Listeners

194 Listeners

141 Listeners

518 Listeners

367 Listeners

5 Listeners

183 Listeners

19 Listeners

6 Listeners